13 results on '"Faruqe, Md Omar"'
Search Results
2. Molecular docking and dynamics simulation approach of Camellia sinensis leaf extract derived compounds as potential cholinesterase inhibitors
- Author
-
Hosen, Md. Eram, Rahman, Md. Sojiur, Faruqe, Md Omar, Khalekuzzaman, Md., Islam, Md. Asadul, Acharjee, Uzzal Kumar, and Zaman, Rashed
- Published
- 2023
- Full Text
- View/download PDF
3. Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (Mpro) using molecular docking and deep learning methods
- Author
-
Hossain, Alomgir, Rahman, Md Ekhtiar, Rahman, Md Siddiqur, Nasirujjaman, Khondokar, Matin, Mohammad Nurul, Faruqe, Md Omar, and Rabbee, Muhammad Fazle
- Published
- 2023
- Full Text
- View/download PDF
4. Robust identification of common genomic biomarkers from multiple gene expression profiles for the prognosis, diagnosis, and therapies of pancreatic cancer
- Author
-
Hossen, Md Bayazid, Islam, Md Ariful, Reza, Md Selim, Kibria, Md Kaderi, Horaira, Md Abu, Tuly, Khanis Farhana, Faruqe, Md Omar, Kabir, Firoz, and Mollah, Md Nurul Haque
- Published
- 2023
- Full Text
- View/download PDF
5. Effects of Bacille Calmette Guerin (BCG) vaccination during COVID-19 infection
- Author
-
Chowdhury, Utpala Nanda, Faruqe, Md Omar, Mehedy, Md, Ahmad, Shamim, Islam, M. Babul, Shoombuatong, Watshara, Azad, A.K.M., and Moni, Mohammad Ali
- Published
- 2021
- Full Text
- View/download PDF
6. Exploring the Therapeutic Potential of Petiveria alliacea L. Phytochemicals: A Computational Study on Inhibiting SARS-CoV-2's Main Protease (Mpro).
- Author
-
Ali, Md. Ahad, Sheikh, Humaira, Yaseen, Muhammad, Faruqe, Md Omar, Ullah, Ihsan, Kumar, Neeraj, Bhat, Mashooq Ahmad, and Mollah, Md. Nurul Haque
- Subjects
SARS-CoV-2 ,PROTEIN receptors ,MOLECULAR docking ,SYNTHETIC drugs ,MOLECULAR dynamics - Abstract
The outbreak of SARS-CoV-2, also known as the COVID-19 pandemic, is still a critical risk factor for both human life and the global economy. Although, several promising therapies have been introduced in the literature to inhibit SARS-CoV-2, most of them are synthetic drugs that may have some adverse effects on the human body. Therefore, the main objective of this study was to carry out an in-silico investigation into the medicinal properties of Petiveria alliacea L. (P. alliacea L.)-mediated phytocompounds for the treatment of SARS-CoV-2 infections since phytochemicals have fewer adverse effects compared to synthetic drugs. To explore potential phytocompounds from P. alliacea L. as candidate drug molecules, we selected the infection-causing main protease (Mpro) of SARS-CoV-2 as the receptor protein. The molecular docking analysis of these receptor proteins with the different phytocompounds of P. alliacea L. was performed using AutoDock Vina. Then, we selected the three top-ranked phytocompounds (myricitrin, engeletin, and astilbin) as the candidate drug molecules based on their highest binding affinity scores of −8.9, −8.7 and −8.3 (Kcal/mol), respectively. Then, a 100 ns molecular dynamics (MD) simulation study was performed for their complexes with Mpro using YASARA software, computed RMSD, RMSF, PCA, DCCM, MM/PBSA, and free energy landscape (FEL), and found their almost stable binding performance. In addition, biological activity, ADME/T, DFT, and drug-likeness analyses exhibited the suitable pharmacokinetics properties of the selected phytocompounds. Therefore, the results of this study might be a useful resource for formulating a safe treatment plan for SARS-CoV-2 infections after experimental validation in wet-lab and clinical trials. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Evaluation of Adenanthera pavonina-derived compounds against diabetes mellitus: insight into the phytochemical analysis and in silico assays.
- Author
-
Rahman, Md. Sojiur, Hosen, Md. Eram, Faruqe, Md. Omar, Khalekuzzaman, Md., Islam, Md. Asadul, Acharjee, Uzzal Kumar, Bin Jardan, Yousef A., Nafidi, Hiba-Allah, Mekonnen, Amare Bitew, Bourhia, Mohammed, and Zaman, Rashed
- Published
- 2024
- Full Text
- View/download PDF
8. Modulating the antibacterial effect of the existing antibiotics along with repurposing drug metformin.
- Author
-
Faruqe, Md Omar
- Abstract
Owing to the extensive prevalence of resistant bacteria to numerous antibiotic classes, antimicrobial resistance (AMR) poses a well-known hazard to world health. As an alternate approach in the field of antimicrobial drug discovery, repurposing the available medications which are also called antibiotic resistance breakers has been pursued for the treatment of infections with antimicrobial resistance pathogens. In this study, we used Haloperidol, Metformin and Hydroxychloroquine as repurposing drugs in in vitro (Antibacterial Antibiotic Sensitivity Test and Minimum Inhibitory Concentration-MIC) and in vivo (Shigellosis in Swiss albino mice) tests in combination with traditional antibiotics (Oxytetracycline, Erythromycin, Doxycycline, Gentamicin, Ampicillin, Chloramphenicol, and Penicillin) against a group of AMR resistance bacteria (Bacillus cereus, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Shigella boydii). After observing the results of the conducted in vitro experiments we studied the effects of the above non antibiotic drugs in combination with the said antibiotics. As an repurposing adjuvant antibiotic drug, Metformin exhibited noteworthy activity in almost all in vitro, in vivo and in silico tests (Zone of inhibition for 30 to 43 mm for E.coli in combination with Doxycycline; MIC value decreased 50 µM to 0.781 µM with Doxycycline on S. boydii).In rodents Doxycycline and Metformin showed prominent against Shigellosis in White blood cell count (6.47 ± 0.152 thousand/mm3) and Erythrocyte sedimentation rate (10.5 ± 1.73 mm/hr). Our findings indicated that Metformin and Doxycycline combination has a crucial impact on Shigellosis. The molecular docking study was performed targeting the Acriflavine resistance protein B (AcrB) (PDB ID: 4CDI) and MexA protein (PDB ID: 6IOK) protein with Metformin (met8) drug which showed the highest binding energy with − 6.4 kcal/mol and − 5.5 kcal/mol respectively. Further, molecular dynamics simulation revealed that the docked complexes were relatively stable during the 100 ns simulation period. This study suggest Metformin and other experimented drugs can be used as adjuvants boost up antibiosis but further study is needed to find out the safety and efficacy of this non-antibiotic drug as potent antibiotic adjuvant. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Characterization of Plant-Derived Natural Inhibitors of Dipeptidyl Peptidase-4 as Potential Antidiabetic Agents: A Computational Study.
- Author
-
Hossain, Alomgir, Rahman, Md Ekhtiar, Faruqe, Md Omar, Saif, Ahmed, Suhi, Suzzada, Zaman, Rashed, Hirad, Abdurahman Hajinur, Matin, Mohammad Nurul, Rabbee, Muhammad Fazle, and Baek, Kwang-Hyun
- Subjects
CD26 antigen ,MOLECULAR dynamics ,PRINCIPAL components analysis ,DENSITY functional theory ,GLUCOSE metabolism ,T cells - Abstract
Diabetes, characterized by elevated blood sugar levels, poses significant health and economic risks, correlating with complications like cardiovascular disease, kidney failure, and blindness. Dipeptidyl peptidase-4 (DPP-4), also referred to as T-cell activation antigen CD26 (EC 3.4.14.5.), plays a crucial role in glucose metabolism and immune function. Inhibiting DPP-4 was anticipated as a potential new therapy for diabetes. Therefore, identification of plant-based natural inhibitors of DPP-4 would help in eradicating diabetes worldwide. Here, for the identification of the potential natural inhibitors of DPP-4, we developed a phytochemicals library consisting of over 6000 phytochemicals detected in 81 medicinal plants that exhibited anti-diabetic potency. The library has been docked against the target proteins, where isorhamnetin, Benzyl 5-Amino-5-deoxy-2,3-O-isopropyl-alpha-D-mannofuranoside (DTXSID90724586), and 5-Oxo-7-[4-(trifluoromethyl) phenyl]-4H,6H,7H-[1,2]thiazolo[4,5-b]pyridine 3-carboxylic acid (CHEMBL3446108) showed binding affinities of −8.5, −8.3, and −8.3 kcal/mol, respectively. These compounds exhibiting strong interactions with DPP-4 active sites (Glu205, Glu206, Tyr547, Trp629, Ser630, Tyr662, His740) were identified. ADME/T and bioactivity predictions affirmed their pharmacological safety. Density functional theory calculations assessed stability and reactivity, while molecular dynamics simulations demonstrated persistent stability. Analyzing parameters like RMSD, RG, RMSF, SASA, H-bonds, MM-PBSA, and FEL confirmed stable protein–ligand compound formation. Principal component analysis provided structural variation insights. Our findings suggest that those compounds might be possible candidates for developing novel inhibitors targeting DPP-4 for treating diabetes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Mechanistic insight of Staphylococcus aureus associated skin cancer in humans by Santalum album derived phytochemicals: an extensive computational and experimental approaches.
- Author
-
Hosen, Md. Eram, Supti, Sumaiya Jahan, Akash, Shopnil, Rahman, Md. Ekhtiar, Faruqe, Md Omar, Manirujjaman, M., Acharjee, Uzzal Kumar, Gaafar, Abdel-Rhman Z., Ouahmane, Lahcen, Sitotaw, Baye, Bourhia, Mohammed, Zaman, Rashed, Murahari, Manikanta, Shaker, Bilal, and Darwish, Khaled Mohamed
- Subjects
STAPHYLOCOCCUS aureus ,SKIN cancer ,SANDALWOOD ,BOTANICAL chemistry ,COMPUTATIONAL chemistry - Abstract
An excessive amount of multidrug-resistant Staphylococcus aureus is commonly associated with actinic keratosis (AK) and squamous cell carcinoma (SCC) by secreted virulence products that induced the chronic inflammation leading to skin cancer which is regulated by staphylococcal accessory regulator (SarA). It is worth noting that there is currently no existing published study that reports on the inhibitory activity of phytochemicals derived from Santalum album on the SarA protein through in silico approach. Therefore, our study has been designed to find the potential inhibitors of S. aureus SarA protein from S. album-derived phytochemicals. The molecular docking study was performed targeting the SarA protein of S. aureus, and CID:5280441, CID:162350, and CID: 5281675 compounds showed the highest binding energy with -9.4 kcal/mol, -9.0 kcal/mol, and -8.6 kcal/mol respectively. Further, molecular dynamics simulation revealed that the docked complexes were relatively stable during the 100 ns simulation period whereas the MMPBSA binding free energy proposed that the ligands were sustained with their binding site. All three complexes were found to be similar in distribution with the apoprotein through PCA analysis indicating conformational stability throughout the MD simulation. Moreover, all three compounds' ADMET profiles revealed positive results, and the AMES test did not show any toxicity whereas the pharmacophore study also indicates a closer match between the pharmacophore model and the compounds. After comprehensive in silico studies we evolved three best compounds, namely, Vitexin, Isovitexin, and Orientin, which were conducted in vitro assay for further confirmation of their inhibitory activity and results exhibited all of these compounds showed strong inhibitory activity against S. aureus. The overall result suggests that these compounds could be used as a natural lead to inhibit the pathogenesis of S. aureus and antibiotic therapy for S. aureus-associated skin cancer in humans as well. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
11. Unveiling Neuroprotective Potential of Spice Plant-Derived Compounds against Alzheimer's Disease: Insights from Computational Studies.
- Author
-
Alom, Md. Murshid, Bonna, Rejwana Parvin, Islam, Ariful, Alom, Md. Wasim, Rahman, Md. Ekhtiar, Faruqe, Md Omar, Khalekuzzaman, Md., Zaman, Rashed, and Islam, Md. Asadul
- Subjects
PHYTOTHERAPY ,ALZHEIMER'S disease prevention ,PROTEINS ,COMPUTER software ,COMPUTER simulation ,ACETYLCHOLINESTERASE ,ALZHEIMER'S disease ,FLAVONOIDS ,TERPENES ,MOLECULAR models ,SPICES ,WORLD health ,PHYTOCHEMICALS ,QUERCETIN ,NEUROPROTECTIVE agents ,FACTOR analysis ,CHOLINESTERASES ,COMPUTER-assisted molecular modeling ,DONEPEZIL ,LIGANDS (Biochemistry) ,ENZYME inhibitors ,PHARMACODYNAMICS - Abstract
Alzheimer's disease (AD) is a serious threat to the global health care system and is brought on by a series of factors that cause neuronal dysfunction and impairment in memory and cognitive decline. This study investigated the therapeutic potential of phytochemicals that belong to the ten regularly used spice plants, based on their binding affinity with AD-associated proteins. Comprehensive docking studies were performed using AutoDock Vina in PyRx followed by molecular dynamic (MD) simulations using AMBER 14. The docking study of the chosen molecules revealed the binding energies of their interactions with the target proteins, while MD simulations were carried out to verify the steadiness of bound complexes. Through the Lipinski filter and admetSAR analysis, the chosen compounds' pharmacokinetic characteristics and drug likeness were also examined. The pharmacophore mapping study was also done and analyzed for best selected molecules. Additionally, principal component analysis (PCA) was used to examine how the general motion of the protein changed. The results showed quercetin and myricetin to be potential inhibitors of AChE and alpha-amyrin and beta-chlorogenin to be potential inhibitors of BuChE, exhibiting best binding energies comparable to those of donepezil, used as a positive control. The multiple descriptors from the simulation study, root mean square deviation (RMSD), root mean square fluctuation (RMSF), hydrogen bond, radius of gyration (Rg), and solvent-accessible surface areas (SASA), confirm the stable nature of the protein-ligand complexes. Molecular mechanic Poisson-Boltzmann surface area (MM-PBSA) binding free energy calculations indicated the energetically favorable binding of the ligands to the protein. Finally, according to pharmacokinetic properties and drug likeness, characteristics showed that quercetin and myricetin for AChE and alpha-amyrin and beta-chlorogenin for BuChE were found to be the most effective agents for treating the AD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Exploring Prognostic Biomarkers of Acute Myeloid Leukemia to Determine Its Most Effective Drugs from the FDA-Approved List through Molecular Docking and Dynamic Simulation.
- Author
-
Alom, Md. Murshid, Faruqe, Md Omar, Molla, Md. Khademul Islam, and Rahman, Md Motiur
- Subjects
- *
BIOMARKERS , *DRUG approval , *BIOCHEMISTRY , *PHENOMENOLOGICAL biology , *BIOINFORMATICS , *GENE expression , *GENES , *SURVIVAL analysis (Biometry) , *RESEARCH funding , *COMPUTER-assisted molecular modeling , *MOLECULAR structure - Abstract
Acute myeloid leukemia (AML) is a blood cancer caused by the abnormal proliferation and differentiation of hematopoietic stem cells in the bone marrow. The actual genetic markers and molecular mechanisms of AML prognosis are unclear till today. This study used bioinformatics approaches for identifying hub genes and pathways associated with AML development to uncover potential molecular mechanisms. The expression profiles of RNA-Seq datasets, GSE68925 and GSE183817, were retrieved from the Gene Expression Omnibus (GEO) database. These two datasets were analyzed by GREIN to obtain differentially expressed genes (DEGs), which were used for performing the Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, protein-protein interaction (PPI), and survival analysis. The molecular docking and dynamic simulation were performed to identify the most effective drug/s for AML from the drug list approved by the Food and Drug Administration (FDA). By integrating the two datasets, 238 DEGs were identified as likely to be affected by AML progression. GO enrichment analyses exhibited that the upregulated genes were mainly associated with inflammatory response (BP) and extracellular region (CC). The downregulated DEGs were involved in the T-cell receptor signalling pathway (BP), an integral component of the lumenal side of the endoplasmic reticulum membrane (CC) and peptide antigen binding (MF). The pathway enrichment analysis showed that the upregulated DEGs were mainly associated with the T-cell receptor signalling pathway. Among the top 15 hub genes, the expression levels of ALDH1A1 and CFD were associated with the prognosis of AML. Four FDA-approved drugs were selected, and a top-ranked drug was identified for each biomarker through molecular docking studies. The top-ranked drugs were further confirmed by molecular dynamic simulation that revealed their binding stability and confirmed their stable performance. Therefore, the drug compounds, enasidenib and gilteritinib, can be recommended as the most effective drugs against the ALDH1A1 and CFD proteins, respectively. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. Exploring Core Genes by Comparative Transcriptomics Analysis for Early Diagnosis, Prognosis, and Therapies of Colorectal Cancer.
- Author
-
Islam, Md. Ariful, Hossen, Md. Bayazid, Horaira, Md. Abu, Hossen, Md. Alim, Kibria, Md. Kaderi, Reza, Md. Selim, Tuly, Khanis Farhana, Faruqe, Md. Omar, Kabir, Firoz, Mahumud, Rashidul Alam, and Mollah, Md. Nurul Haque
- Subjects
DISEASE progression ,BIOMARKERS ,ALKALOIDS ,EARLY detection of cancer ,CELL cycle proteins ,COLORECTAL cancer ,GENE expression ,BIOINFORMATICS ,CANCER patients ,CELLULAR signal transduction ,GENE expression profiling ,BENZOPYRANS ,COMPUTER-assisted molecular modeling - Abstract
Simple Summary: Colorectal cancer (CRC) is a complex disease that has a high mortality rate. This study explored CRC-related core genes (CGs) from multiple microarray gene-expression profiles in the NCBI-GEO database by combining some statistics and bioinformatics techniques. It also disclosed their molecular functions, biological processes, cellular components, signaling pathways, and transcriptional and post-transcriptional regulatory factors by using different online bioinformatics tools and databases. The prognostic power of CGs was investigated from the independent TCGA database by using survival probability curves and box plots of CGs-expressions in different stages (control, Stage 1, Stage 2, Stage 3, and Stage 4) of CRC. Finally, a few CGs-guided drug molecules were suggested for the treatment of CRC by molecular docking and dynamic simulation studies. Therefore, the findings of this study would be useful resources for early diagnosis, prognosis, and therapies of CRC. Colorectal cancer (CRC) is one of the most common cancers with a high mortality rate. Early diagnosis and therapies for CRC may reduce the mortality rate. However, so far, no researchers have yet investigated core genes (CGs) rigorously for early diagnosis, prognosis, and therapies of CRC. Therefore, an attempt was made in this study to explore CRC-related CGs for early diagnosis, prognosis, and therapies. At first, we identified 252 common differentially expressed genes (cDEGs) between CRC and control samples based on three gene-expression datasets. Then, we identified ten cDEGs (AURKA, TOP2A, CDK1, PTTG1, CDKN3, CDC20, MAD2L1, CKS2, MELK, and TPX2) as the CGs, highlighting their mechanisms in CRC progression. The enrichment analysis of CGs with GO terms and KEGG pathways revealed some crucial biological processes, molecular functions, and signaling pathways that are associated with CRC progression. The survival probability curves and box-plot analyses with the expressions of CGs in different stages of CRC indicated their strong prognostic performance from the earlier stage of the disease. Then, we detected CGs-guided seven candidate drugs (Manzamine A, Cardidigin, Staurosporine, Sitosterol, Benzo[a]pyrene, Nocardiopsis sp., and Riccardin D) by molecular docking. Finally, the binding stability of four top-ranked complexes (TPX2 vs. Manzamine A, CDC20 vs. Cardidigin, MELK vs. Staurosporine, and CDK1 vs. Riccardin D) was investigated by using 100 ns molecular dynamics simulation studies, and their stable performance was observed. Therefore, the output of this study may play a vital role in developing a proper treatment plan at the earlier stages of CRC. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.